Due to these beneficial effects of the gut microbiota populations and their metabolites, the fasting serum glucose and insulin levels were lower in VK-supplemented patients with T2DM compared to those in the nonsupplemented control group, demonstrating an improvement in glucose tolerance and insulin sensitivity. Here, INS is linked to type 2 diabetes mellitus.